These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2056187)

  • 1. Percutaneous retinoid absorption and embryotoxicity.
    Nau H
    J Invest Dermatol; 1991 Jul; 97(1):159-60. PubMed ID: 2056187
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous retinoid absorption and embryotoxicity.
    Willhite CC; Sharma RP; Allen PV; Berry DL
    J Invest Dermatol; 1990 Nov; 95(5):523-9. PubMed ID: 2230214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratology of retinoids.
    Collins MD; Mao GE
    Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of co-administration of retinoids on rat embryo development in vitro.
    Ritchie HE; Brown-Woodman PD; Korabelnikoff A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):444-51. PubMed ID: 12962289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids.
    Jiang H; Penner JD; Beard RL; Chandraratna RA; Kochhar DM
    Biochem Pharmacol; 1995 Aug; 50(5):669-76. PubMed ID: 7669070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of disposition data in evaluating retinoid developmental toxicity.
    Willhite CC; Book SA
    Methods Enzymol; 1990; 190():406-17. PubMed ID: 2087192
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are topical retinoids teratogenic?
    Veraldi S; Rossi LC; Barbareschi M
    G Ital Dermatol Venereol; 2016 Dec; 151(6):700-705. PubMed ID: 27598619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
    Willhite CC; Shealy YF
    J Natl Cancer Inst; 1984 Mar; 72(3):689-95. PubMed ID: 6583452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid teratogenesis: toxicokinetics and structure-specificity.
    Nau H
    Arch Toxicol Suppl; 1994; 16():118-27. PubMed ID: 8192573
    [No Abstract]   [Full Text] [Related]  

  • 14. Penetration and metabolism of topical retinoids in ex vivo organ-cultured full-thickness human skin explants.
    Antille C; Tran C; Sorg O; Saurat JH
    Skin Pharmacol Physiol; 2004; 17(3):124-8. PubMed ID: 15087591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythm of embryotoxicity induced by sodium valproate in mice.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Eur J Pharmacol; 1995 Oct; 293(3):281-5. PubMed ID: 8666048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety of tazarotene in the treatment of plaque psoriasis.
    Marks R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity.
    Nau H
    Methods Enzymol; 1990; 190():437-48. PubMed ID: 2150873
    [No Abstract]   [Full Text] [Related]  

  • 18. Delivery of retinoid-based therapies to target tissues.
    Moise AR; Noy N; Palczewski K; Blaner WS
    Biochemistry; 2007 Apr; 46(15):4449-58. PubMed ID: 17378589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratogenicity and embryotoxicity of azaphtalimides].
    Fickentscher K; Günther E; Köhler F
    Pharmazie; 1976; 31(3):172-4. PubMed ID: 959269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.